Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease–Associated Alleles Among Large Population-Based Cohorts
Author(s) -
Sarah L. Gardiner,
Merel W. Boogaard,
Stella Trompet,
Renée de Mutsert,
Frits R. Rosendaal,
Jacobijn Gussekloo,
J. Wouter Jukema,
Raymund A.C. Roos,
N. Ahmad Aziz
Publication year - 2019
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2019.0423
Subject(s) - spinocerebellar ataxia , population , allele , spinal and bulbar muscular atrophy , genetics , disease , biology , pathological , medicine , gene , cancer , prostate cancer , androgen receptor , environmental health
Nine hereditary neurodegenerative diseases are known as polyglutamine diseases, including Huntington disease, 6 spinocerebellar ataxias (SCAs) (SCA1, SCA2, SCA3, SCA6, SCA7, and SCA17), dentatorubral-pallidoluysion atrophy, and spinal bulbar muscular atrophy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom